Sign in
4

Changes in Ownership

AGIOS PHARMACEUTICALS, INC. Filed Acc 0001439222-25-000073

Chief Medical Officer sold 4,091 shares at $34.17 ($139,789)

  • Chief Medical Officer acquired 8,374 shares (option exercise)
  • Traded under a Rule 10b5-1 plan

From the SEC's structured data for this filing

Trades in this filing

Gheuens Sarah · Chief Medical Officer

Table I: Non-derivative

2 lines
Date Transaction Shares Price Value Owned after D/I
2025-07-01 Exercise or conversion : show line 1 in the form 10b5-1 +8,374 65,362 D
2025-07-01 Sale : show line 2 in the form 10b5-1 −4,091 $34.17 $139,789 61,271 D
Open-market sales · 4,091 sh · avg $34.17 · $139,789

Table II: Derivative

1 line
Date Transaction Shares Owned after D/I
2025-07-01 Exercise or conversion : show line 3 in the form 10b5-1 Restricted stock units −8,374 8,375 D
Loading xslF345X05/wk-form4_1751572884.xml…